By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Acceleron Pharma 

128 Sidney Street

Cambridge  Massachusetts    U.S.A.
Phone: 617-649-9200 Fax: 617-649-9988





Company News
Acceleron Pharma Announces Clinical Presentations On Luspatercept At The 22nd Congress Of European Hematology Association 5/18/2017 8:04:29 AM
Acceleron Pharma Release: Luspatercept Phase II Data Presented At The 14th International Symposium On Myelodysplastic Syndromes 5/8/2017 6:52:26 AM
Acceleron Pharma Reports First Quarter 2017 Operational And Financial Results 5/8/2017 6:17:59 AM
Acceleron Pharma Announces Management Change 5/3/2017 5:39:11 AM
Acceleron Pharma Provides Clinical Development Updates On Luspatercept Program 4/27/2017 8:36:13 AM
Acceleron Pharma To Host Webcast To Review First Quarter 2017 Financial And Operational Results On May 8, 2017 4/26/2017 6:17:08 AM
Acceleron Pharma Announces Plans To Initiate A Phase II Trial Of ACE-083 In Charcot-Marie-Tooth Neuromuscular Disease And Host Educational Webinar 3/16/2017 6:20:37 AM
Acceleron Pharma Reports Fourth Quarter And Year Ended 2016 Operational And Financial Results 3/1/2017 6:25:31 AM
Acceleron Pharma To Webcast Conference Call Of Fourth Quarter And Year Ended 2016 Financial Results On March 1, 2017 2/22/2017 6:39:06 AM
Acceleron Pharma Outlines Corporate Goals And Priorities For 2017 1/6/2017 11:13:22 AM